Je veux savoir à propos de…

khammond on DSKJM1Z7X2PROD with NOTICES

36550

Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices
and other STDs; and 6 advance the education of health professionals and the public from HIV, viral hepatitis, and other STDs.
The CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment meets at least two times each calendar year, or at the discretion of the Designated Federal Officer in consultation with the CHACHSPT cochairs.
The CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment shall advise the Director, CDC, and the Administrator, HRSA, regarding objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STD prevention and treatment efforts, including surveillance of HIV
infection, Acquired Immunodeficiency Syndrome AIDS, viral hepatitis, other STDs, and related behaviors;
epidemiologic, behavioral, health services, and laboratory research on HIV, viral hepatitis, and other STDs;
identification of policy issues related to HIV/viral hepatitis/STD professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV, viral hepatitis and other STDs, treatment, healthcare delivery, and research and training;
strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to the agencies in their development of responses to emerging health needs related to HIV, viral hepatitis and other STDs.
Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committees objectives. Nominees will be selected based on expertise in the fields of public health; epidemiology; laboratory practice; immunology; infectious diseases; drug abuse; behavioral science;
health education; healthcare delivery;
state health programs; clinical care;
preventive health; medical education;
health services and clinical research;
and healthcare financing. The Committee shall also include representation of persons with HIV and other affected populations; state and local health and education agencies;
HIV/viral hepatitis/STD communitybased organizations; and the ethics or faith-based community. Federal employees will not be considered for membership. Members may be invited to serve for up to four-year terms.
Selection of members is based on candidates qualifications to contribute to the accomplishment of CHACHSPT

VerDate Sep<11>2014

17:26 Jul 09, 2021

Jkt 253001

objectives. The U.S. Department of Health and Human Services policy stipulates that committee membership be balanced in terms of points of view represented, and the committees function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees SGEs, requiring the filing of financial disclosure reports at the beginning and annually during their terms. Individuals who are selected for appointment will be required to provide detailed information regarding their financial interests and, for example, any work they do for the federal government through research grants or contracts.
Disclosure of this information is required in order for CDC ethics officials to determine whether there is a conflict between the SGEs public duties as members of CHACHSPT and their private interests, including an appearance of a loss of impartiality as defined by federal laws and regulations, and to identify any required remedial action needed to address the potential conflict. CDC reviews potential candidates for CHACHSPT membership when a vacancy arises and provides a slate of nominees for consideration to the Secretary of HHS for final selection.
HHS notifies selected candidates of their appointment near the start of the term in December 1, 2021, or as soon as the HHS selection process has been completed. Note that the need for different expertise varies from year to year and a candidate who is not selected for an open position may be reconsidered for a subsequent open position. SGE nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government.
Candidates should submit the following items:
D Current curriculum vitae or resume, including complete contact information telephone numbers, mailing address, email address.
D At least one letter of recommendation from persons not employed by the U.S. Department of Health and Human Services.

PO 00000

Frm 00029

Fmt 4703

Sfmt 4703

Candidates may submit letterss from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency e.g., CDC, NIH, FDA, etc..
D A biographical sketch of the nominee 500 words or fewer.
D A letter of interest or personal statement from the nominee stating how their expertise would inform the work of CHACHSPT.
Nominations may be submitted directly by the individual seeking nomination or by the person/
organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
FR Doc. 202114686 Filed 7921; 8:45 am BILLING CODE 416318P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and Prevention 60Day2121GH; Docket No. CDC2021
0065

Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention CDC, Department of Health and Human Services HHS.
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease Control and Prevention CDC, as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995.
This notice invites comment on a proposed information collection project titled Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum. This proposed collection will collect data to evaluate
SUMMARY:

E:FRFM12JYN1.SGM

12JYN1